MEDigest is a quarterly communication tool aimed to disseminate state-of-the-art medical information to stimulate scientific communication and encourage new ideas which will help cultivate knowledge and hopefully inspire us to develop new skill sets.

The quarterly communication platform will feature the latest advancements in multiple disciplines in medicine with key focus in the most recent developments in medicine and technology focused on kidney care, critical care, regenerative medicine, advanced diagnostics and artificial intelligence, to name a few.

Issue #20- HEMODIAFILTRATION- BASIC CONCEPTS, PRACTICAL ASPECTS, AND COST CONSEQUENCES

Issue #21- GENETIC TESTING AND EMERGING THERAPIES FOR GENETIC KIDNEY DISEASES

Issue #22- DIALYZER MEMBRANES: CURRENT TECHNOLOGY & ADVANCEMENTS

Issue #23- APPLICATIONS OF ARTIFICIAL INTELLIGENCE IN CKD

Issue #24- PALLIATIVE CARE IN KIDNEY FAILURE PATIENTS

Issue #25-THE ROLE OF BIOMARKERS IN ACUTE KIDNEY INJURY

Issue #26-CHRONIC KIDNEY DISEASE AND MENTAL HEALTH

Issue #27-TECHNIQUE FAILURE IN PERITONEAL DIALYSIS

Issue #28-FATIGUE IN CHRONIC KIDNEY DISEASE

Issue #29-NUTRITION IN HEMODIALYSIS PATIENTS

Issue#30-NEW INSIGHTS OF REGENERATIVE MEDICINES: HUMAN ACELLULAR VESSELS

Issue #31 CHRONIC KIDNEY DISEASE – ASSOCIATED PRURITUS (CKD-aP)

Issue #32 XENOTRANSPLANTATION: OVERCOMING IMMUNE BARRIERS

Issue #33 PATIENT-REPORTED OUTCOME MEASURES IN KIDNEY DISEASE

Issue #34- REMOTE PATIENT MONITORING 

Issue #35- EXERCISE IN DIALYSIS PATIENTS

Issue #36- DIALYSIS IN PREGNANCY

Issue #37- HEMODIAFILTRATION ADVANCEMENTS IN PEDIATRICS

Issue #38- INFECTIONS IN HEMODIALYSIS PATIENTS: NAVIGATING HBV, HCV, AND COVID-19

Disclosure:
This material has been developed by the Fresenius Medical Care Global Medical Information and Education Office and Global Medical Office. It is intended to provide pertinent data to assist health care professional in forming their own conclusions and making decisions and not intended to replace the judgement or experience of the attending physicians or other medical professionals. Any such use of drug or devices should not be considered an endorsement of any indication, dosage or other claim that is not covered, if applicable, in the label approved by your regulatory authority. The treatment prescription is the sole responsibility of the attending physician.
Fresenius Medical Care, the triangle logo, and the Advanced Renal Education (AREP) logo are trademarks of Fresenius Medical Care Holdings, Inc., or its affiliated companies.

Contact Us:

For suggestions and comments email us at: Medical_Information_Education@freseniusmedicalcare.com

Global Medical Education and Information,
Fresenius Medical Care Asia Pacific,
5105-5123 & 5141, 51/F Sun Hung Kai Centre,
30 Harbour Road, Wan Chai, Hong Kong

Back To Top